Zobrazeno 1 - 10
of 15
pro vyhledávání: '"BÁRBARA PESCE"'
Autor:
Paulina A. García-González, Jaxaira Maggi, Katina Schinnerling, Alejandro Sepúlveda-Gutiérrez, Lilian Soto, Oscar Neira, Ahmed M. Mehdi, Hendrik J. Nel, Bárbara Pesce, Octavio Aravena, María Carmen Molina, Diego Catalán, Ranjeny Thomas, Ricardo A. Verdugo, Juan Carlos Aguillón
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
The potential of tolerogenic dendritic cells (tolDCs) to shape immune responses and restore tolerance has turn them into a promising therapeutic tool for cellular therapies directed toward immune regulation in autoimmunity. Although the cellular mech
Externí odkaz:
https://doaj.org/article/7fb74e75ba6b42cab167b149b15c222c
Autor:
Paulina A. García-González, Katina Schinnerling, Alejandro Sepúlveda-Gutiérrez, Jaxaira Maggi, Ahmed M. Mehdi, Hendrik J. Nel, Bárbara Pesce, Milton L. Larrondo, Octavio Aravena, María C. Molina, Diego Catalán, Ranjeny Thomas, Ricardo A. Verdugo, Juan C. Aguillón
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
There is growing interest in the use of tolerogenic dendritic cells (tolDCs) as a potential target for immunotherapy. However, the molecular bases that drive the differentiation of monocyte-derived DCs (moDCs) toward a tolerogenic state are still poo
Externí odkaz:
https://doaj.org/article/f7d45918c8324f22a733ba8475b062f6
Autor:
Paulina Andrea García-González, Katina Schinnerling, Alejandro Sepúlveda-Gutiérrez, Jaxaira Maggi, Lorena Hoyos, Rodrigo A Morales, Ahmed M Medhi, Hendrik J Nel, Lilian Soto, Bárbara Pesce, María Carmen Molina, Miguel Cuchacovich, Milton Larrondo, Oscar Neira, Diego Francisco Catalán, Catharien Hilkens, Ranjeny Thomas, Ricardo A Verdugo, Juan C Aguillon
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Tolerogenic dendritic cells (TolDCs) are promising tools for therapy of autoimmune diseases such as rheumatoid arthritis (RA). Here we characterise monocyte-derived TolDCs from RA patients modulated with dexamethasone and activated with monophosphory
Externí odkaz:
https://doaj.org/article/f0aae893e2464f81ac785add7f2d9d67
Autor:
Jaxaira Maggi, Katina Schinnerling, Bárbara Pesce, Catharien M Hilkens, Diego Catalán, Juan C Aguillón
Publikováno v:
Frontiers in Immunology, Vol 7 (2016)
Tolerogenic dendritic cells (DCs) are a promising tool to control T cell-mediated autoimmunity. Here, we evaluate the ability of dexamethasone-modulated and monophosphoryl lipid A-activated DCs (MPLA-tDCs) to exert immunomodulatory effects on naïve
Externí odkaz:
https://doaj.org/article/39b4901bec31430e83155c9668681fe6
Autor:
Leonel A Cortes, Lorena Castro, Bárbara Pesce, Juan D Maya, Jorge Ferreira, Vicente Castro-Castillo, Eduardo Parra, José A Jara, Rodrigo López-Muñoz
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0136852 (2015)
disease is one of the most neglected tropical diseases in the world, affecting nearly 15 million people, primarily in Latin America. Only two drugs are used for the treatment of this disease, nifurtimox and benznidazole. These drugs have limited effi
Externí odkaz:
https://doaj.org/article/bf600f884ddd4010ae450b5345fb15ba
Autor:
IRENE SCHIATTINO, RODRIGO VILLEGAS, ANDREA CRUZAT, JIMENA CUENCA, LORENA SALAZAR, OCTAVIO ARAVENA, BÁRBARA PESCE, DIEGO CATALÁN, CAROLINA LLANOS, MIGUEL CUCHACOVICH, JUAN C AGUILLÓN
Publikováno v:
Biological Research, Vol 38, Iss 1, Pp 7-12 (2005)
Longitudinal studies aimed at evaluating patients clinical response to specific therapeutic treatments are frequently summarized in incomplete datasets due to missing data. Multivariate statistical procedures use only complete cases, deleting any cas
Externí odkaz:
https://doaj.org/article/ee963a49aa194aa2b84aa4af858aa5bd
Autor:
Bárbara Pesce, Carolina H. Ribeiro, Milton Larrondo, Verónica Ramos, Lilian Soto, Diego Catalán, Juan Carlos Aguillón
Publikováno v:
International Journal of Molecular Sciences; Volume 23; Issue 16; Pages: 9306
Tumor necrosis factor (TNF)-α is a pleiotropic cytokine implicated in the etiology of several autoimmune diseases, including rheumatoid arthritis (RA). TNF-α regulates diverse effector functions through the activation of TNF-α receptor (TNFR)1 and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d38968010b3d159a07b2279b7bb12aa
Autor:
Juan C, Aguillón, Andrea, Cruzat, Juan, Contreras-Levicoy, Andrés, Dotte, Bárbara, Pesce, Octavio, Aravena, Lorena, Salazar, Diego, Catalán, Paula, Abello, Adam, Aguirre, Carolina, Llanos, Miguel, Cuchacovich
Publikováno v:
Revista medica de Chile. 133(8)
The use of biological agents such as etanercept, infliximab, adalimumab and anakinra has been recently approved for the treatment of rheumatoid arthritis. All are effective controlling signs and symptoms and inhibiting disease progression. To overcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::41aff733a7a309d73a823d904387b1d4
https://pubmed.ncbi.nlm.nih.gov/16163436
https://pubmed.ncbi.nlm.nih.gov/16163436
Autor:
Carolina Llanos M, Juan C Aguillón G, Juan Contreras-Levicoy, Diego Catalán M, Andrés Dotte G, Paula Abello C, Miguel Cuchacovich T, Adam Aguirre D, Octavio Aravena M, Bárbara Pesce R, Andrea Cruzat C, Lorena Salazar A
Publikováno v:
Revista médica de Chile v.133 n.8 2005
SciELO Chile
CONICYT Chile
instacron:CONICYT
SciELO Chile
CONICYT Chile
instacron:CONICYT
The use of biological agents such as etanercept, infliximab, adalimumab and anakinra has been recently approved for the treatment of rheumatoid arthritis. All are effective controlling signs and symptoms and inhibiting disease progression. To overcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cfcc27a48294d98fb6897f2d2113967
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000800014
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872005000800014
Autor:
Carolina Campos-Estrada, Ana Liempi, Fabiola González-Herrera, Michel Lapier, Ulrike Kemmerling, Barbara Pesce, Jorge Ferreira, Rodrigo López-Muñoz, Juan D Maya
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 9, Iss 5, p e0003770 (2015)
Trypanosoma cruzi is the causal agent of Chagas Disease that is endemic in Latin American, afflicting more than ten million people approximately. This disease has two phases, acute and chronic. The acute phase is often asymptomatic, but with time it
Externí odkaz:
https://doaj.org/article/e0b006411ffa4c3c9585546116676e11